UK-based pharmaceutical giant AstraZeneca plans to build its largest drug manufacturing facility in Virginia, creating hundreds of new jobs as part of a $50 billion investment in the United States.

Virginia Gov. Glenn Youngkin is speaking out about the recent announcement that the state is poised to become a global hub for biopharmaceutical manufacturing, with AstraZeneca. The company chose the Commonwealth for its largest single manufacturing investment worldwide.

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The proposed site was not disclosed.

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.

Governor Glenn Youngkin announced Monday that AstraZeneca selected Virginia for a multi-billion-dollar manufacturing center

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and elsewhere, as well as R&D investment.

AstraZeneca (LSE:AZN) recently announced plans to invest $50 billion in the U.S. by 2030, including the development of a major manufacturing facility in Virginia. Despite this significant announcement and other positive developments such as the EU approval of IMFINZI for bladder cancer,